question: Q:A 38-year-old woman is diagnosed with a stage IIIa infiltrating ductal carcinoma involving the left breast. The tumor is ER/PR positive, HER-2 negative, poorly differentiated Bloom-Richardson grade 3. 4/20 regional nodes are positive. The patient undergoes a lumpectomy with axillary lymph node dissection, followed by chemotherapy and radiation therapy to the left breast and axilla. Her chemotherapy regimen involves doxorubicin, cyclophosphamide, and paclitaxel. Following completion of the intensive phase, she is started on tamoxifen as an adjuvant therapy. 6 months later, she presents with increasing fatigue, orthopnea, and paroxysmal nocturnal dyspnea. Physical examination reveals the presence of an S3 gallop, jugular venous distension (JVD), pedal edema, and ascites. She is diagnosed with congestive cardiac failure and admitted for further management. An echocardiogram confirms the diagnosis of dilated cardiomyopathy with severe diastolic dysfunction and an ejection fraction of 10%. Her medical history prior to the diagnosis of breast cancer is negative for any cardiac conditions. The baseline echocardiogram prior to starting chemotherapy and a 12-lead electrocardiogram were normal. Which of the following is most likely responsible for her current cardiac condition?? 
  {'A': 'Doxorubicin', 'B': 'Radiation therapy', 'C': 'Tamoxifen', 'D': 'Cyclophosphamide', 'E': 'Myocarditis'},